These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 22152384)

  • 1. [Efficacy of interferon alpha with ribavirin for treatment of chronic Hepatitis C].
    Tao J; Liu J; Pu D; Lei H
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):683-5. PubMed ID: 22152384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM; Sheen IS; Liaw YF
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V; Núñez M; Camino N; Maida I; Barreiro P; Romero M; Martin-Carbonero L; Garcia-Samaniego J; González-Lahoz J
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-treatment of children with chronic hepatitis C who did not respond to interferon-alpha treatment.
    Gerner P; Hilbich J; Wenzl TG; Behrens R; Walther F; Kliemann G; Enninger A; Wirth S
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):187-90. PubMed ID: 20512050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy.
    Kumthip K; Chusri P; Pantip C; Thongsawat S; O'Brien A; Nelson KE; Maneekarn N
    J Med Virol; 2014 Aug; 86(8):1360-5. PubMed ID: 24777626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined interferon and ribavirin therapy for chronic hepatitis C in Taiwan.
    Lai MY
    Intervirology; 2006; 49(1-2):91-5. PubMed ID: 16166795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypes of hepatitis C virus in relapsed and non-respondent patients and their response to anti-viral therapy in district Mardan, Khyber Pakhtunkhawa, Pakistan.
    Akhtar N; Bilal M; Rizwan M; Khan MA; Khan A
    Asian Pac J Cancer Prev; 2015; 16(3):1037-40. PubMed ID: 25735327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes 1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirin combination therapy.
    Chusri P; Kumthip K; Pantip C; Thongsawat S; O'Brien A; Maneekarn N
    Virus Res; 2015 Jan; 196():37-43. PubMed ID: 25445343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV clearance patterns in saliva and serum of patients with chronic HCV infection under interferon plus ribavirin therapy.
    Diz Dios P; Castro A; Rodríguez I; Reforma NG; Castro M; Eirea M; Hermida M
    J Oral Pathol Med; 2005 May; 34(5):308-11. PubMed ID: 15817075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C.
    Shakoor A; Shafqat F; Mehmud Te; Akram M; Riaz S; Iqbal Z; Khan AA
    J Ayub Med Coll Abbottabad; 2010; 22(4):6-9. PubMed ID: 22455250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological Response to Conventional Interferon Therapy Combined with Ribavirin against Various HCV Genotypes in Khyber Pakhtunkhwa, Pakistan.
    Ali S; Ahmad B; Ali I; Mahmood N; Anwar N; Saeedi I; Afridi JZ
    Asian Pac J Cancer Prev; 2016; 17(5):2407-10. PubMed ID: 27268605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-alpha and ribavirin in patients with chronic hepatitis C.
    Jiao J; Wang JB
    Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):80-3. PubMed ID: 15730926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of interferon in combination with ribavirin on the plus and minus strands of hepatitis C virus RNA in patients with hepatitis].
    He Y; Liu W; Zeng L
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):32-5. PubMed ID: 9275644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of interferon alone and with ribavirin in patients of chronic hepatitis C.
    Niaz A
    J Coll Physicians Surg Pak; 2003 Aug; 13(8):433-5. PubMed ID: 12921677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C.
    Mihm U; Ackermann O; Welsch C; Herrmann E; Hofmann WP; Grigorian N; Welker MW; Lengauer T; Zeuzem S; Sarrazin C
    J Hepatol; 2009 Jan; 50(1):49-58. PubMed ID: 19022516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.